NCT06803095 Efficacy of Walking Exercise With Dog on Tinnitus Complaints in Sleep Apnea (Obstructive Sleep Apnea)
| NCT ID | NCT06803095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Tinnitus, Subjective |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-12-12 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-12-12 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
there is evidence that tinnitus (chronic subjective form) is highly prevalent among patients with obstructive sleep apnea. exercise is recommneded in chronic subjective form) and obstructive sleep apnea. walking with dog increase adherence to walking to maintain continuity of physical activity
Eligibility Criteria
Inclusion Criteria: * obese persons * bilateral chronic subjective tinnitus * mild obstructive sleep apnea (mild apnea hypopnea index) * forty participants Exclusion Criteria: * body mass index more than 40 kg/m2. * cardiovascular problems * hepatorenal probelms * autoimmune problems * orthopedic probelms
Contact & Investigator
Ali Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06803095 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 45 Years, studying Tinnitus, Subjective. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06803095 currently recruiting?
Yes, NCT06803095 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT06803095 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT06803095 clinical trial?
NCT06803095 is sponsored by Cairo University. The principal investigator is Ali Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.